Abstract | OBJECTIVES: METHODS:
PHT-427 was encapsulated in single- emulsion and double- emulsion PLGA nanoparticles (SE-PLGA-427 and DE-PLGA-427). The drug release rate was evaluated to assess the effect of the second PLGA layer of DE-PLGA-427. Ex vivo cryo-imaging and drug extraction from ex vivo organs was used to assess the whole-body biodistribution in an orthotopic model of MIA PaCa-2 pancreatic cancer. Anatomical magnetic resonance imaging (MRI) was used to noninvasively assess the effects of 4 weeks of nanoparticle drug treatment on tumor size, and diffusion-weighted MRI longitudinally assessed changes in tumor cellularity. RESULTS: DE-PLGA-427 showed delayed drug release and longer drug retention in the pancreas relative to SE-PLGA-427. Diffusion-weighted MRI indicated a consistent decrease in cellularity during drug treatment with both types of drug-loaded nanoparticles. Both SE- and DE-PLGA-427 showed a 6-fold and 4-fold reduction in tumor volume relative to untreated tumors and an elimination of primary pancreatic tumor in 68% of the mice. CONCLUSIONS:
|
Authors | Joseph E Kobes, Iman Daryaei, Christine M Howison, Jordan G Bontrager, Rachael W Sirianni, Emmanuelle J Meuillet, Mark D Pagel |
Journal | Pancreas
(Pancreas)
Vol. 45
Issue 8
Pg. 1158-66
(09 2016)
ISSN: 1536-4828 [Electronic] United States |
PMID | 26918875
(Publication Type: Journal Article)
|
Chemical References |
- Pdk1 protein, mouse
- Protein Kinase Inhibitors
- Pyruvate Dehydrogenase Acetyl-Transferring Kinase
- Polyglycolic Acid
- Lactic Acid
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins c-akt
|
Topics |
- Animals
- Cell Line, Tumor
- Lactic Acid
- Mice
- Nanoparticles
- Pancreatic Neoplasms
- Polyglycolic Acid
- Protein Kinase Inhibitors
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins c-akt
- Pyruvate Dehydrogenase Acetyl-Transferring Kinase
- Tissue Distribution
|